Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Euro Surveill ; 17(2)2012 Jan 12.
Artigo em Inglês | MEDLINE | ID: mdl-22264864

RESUMO

The 2009 influenza pandemic has introduced the new re-assorted influenza A(H1N1)pdm09 virus which recirculated during the 2010/11 influenza season. Before that season, it was possible to acquire protective immunity either by pandemic or seasonal influenza vaccination against influenza A(H1N1)pdm09 or by natural infection. To obtain data on vaccination coverage and antibody levels in a reference population and to calculate whether or not the herd immunity threshold (HIT, calculated as 33% given an R0 of 1.5) was reached at the beginning of the 2010/11 season we performed a seroprevalence study in November 2010 in Hamburg, Germany. Antibody titres were assessed applying a haemagglutination inhibition test. Vaccination coverage was very low: 14% for pandemic and 11% for seasonal 2010/11 vaccinations. Even in those with underlying risk factors, vaccination coverage was not much higher: 17% for both vaccines. Serological analysis revealed antibody titres of ≥1:10 in 135 of 352 (38%) and of ≥1:40 in 61 of 352 study participants (17%). Specific antibodies were measurable in 26% of those without history of vaccination or natural infection, indicating a high proportion of subclinical and mild influenza disease. Nevertheless, the HIT was not reached, leaving the majority of the population susceptible to influenza A(H1N1)pdm09 and its potential complications.


Assuntos
Anticorpos Antivirais/sangue , Vírus da Influenza A Subtipo H1N1/imunologia , Vacinas contra Influenza/administração & dosagem , Vacinas contra Influenza/imunologia , Influenza Humana/epidemiologia , Adolescente , Adulto , Idoso , Estudos Transversais , Alemanha/epidemiologia , Testes de Inibição da Hemaglutinação , Humanos , Influenza Humana/prevenção & controle , Masculino , Pessoa de Meia-Idade , Pandemias , Prevalência , Fatores de Risco , Estações do Ano , Estudos Soroepidemiológicos , Inquéritos e Questionários , Vacinação , Adulto Jovem
2.
Lupus ; 19(1): 89-92, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19933723

RESUMO

Differentiation between lymphadenopathy in potentially life-threatening systemic lupus erythematosus (SLE) and self-limiting necrotizing lymphadenitis, also called Kikuchi- Fujimoto disease (KFD), is difficult. In the past, co-occurrence of SLE and KFD has been described repeatedly in case reports. Here, we report a case of necrotizing lymphadenitis, describe the clinical and histopathologic features in detail and discuss the current literature. KFD may in fact be a histopathologic characteristic of SLE supporting the hypothesis that KFD is a rare manifestation of SLE. To clarify whether KFD is the same entity as lupus lymphadenitis, more cases with SLE and lymphadenopathy should be examined in detail.


Assuntos
Linfadenite Histiocítica Necrosante/etiologia , Lúpus Eritematoso Sistêmico/complicações , Linfadenite/etiologia , Adulto , Linfadenite Histiocítica Necrosante/patologia , Humanos , Lúpus Eritematoso Sistêmico/imunologia , Linfadenite/patologia , Masculino , Necrose
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA